Cardinal Health Inc

NYSE: CAH
$103.37
+$0.54 (+0.5%)
Closing price April 23, 2024
Cardinal Health Inc is a key player in the healthcare sector, offering a wide range of services and products across the globe, including the United States, Canada, Europe, and Asia. The company operates through two main segments: Pharmaceutical and Medical. In the Pharmaceutical segment, it distributes both branded and generic drugs, specialty pharmaceuticals, and over-the-counter products, and offers services to manufacturers and healthcare providers. The Medical segment focuses on manufacturing and distributing medical and surgical supplies, laboratory products, and providing supply chain solutions to various healthcare facilities. Founded in 1979, Cardinal Health is headquartered in Dublin, Ohio, emphasizing its commitment to improving healthcare delivery and efficiency.
The founder of Tesla and SpaceX says he has a "super bad feeling" about the economy. These nine Dividend Aristocrats are in sectors that are defensive and they look poised to do well for the next six...
24/7 Wall St. has screened the Dividend Aristocrats looking for very safe and secure stocks that pay dependable dividends. These eight picks look like great ideas for worried investors in a recession...
Thursday's top analyst upgrades and downgrades included Bill.com, Block, Cardinal Health, Caterpillar, Century Aluminum, Doximity, Flex, Home Depot, Salesforce, Sea, Target, Toast, Under Armour and...
With the potential for a sizable correction looming, here are eight Dividend Aristocrats that are poised to do well for the rest of 2022. With even moderate appreciation in their share prices,...
Tuesday's top analyst upgrades and downgrades included Aptiv, Cardinal Health, Charles Schwab, Chegg, Cisco Systems, CrowdStrike, Franklin Resources, Hewlett Packard Enterprise, Juniper Networks,...
With the interest rates about to begin increasing, the Nasdaq close to bear market territory and the market starting to anticipate recession, it may be a good idea for investors to consider these...
Thursday's top analyst upgrades and downgrades included Advanced Micro Devices, American Eagle Outfitters, Baidu, Broadcom, Cardinal Health, Caterpillar, Fiserv, Halliburton, Match, Microsoft,...
These five Dividend Aristocrats are in sectors that have underperformed in 2021 or are solid plays as investors continue to deal with both rising inflation and the potential for rising interest rates...
Hedge fund managers are getting more defensive, and it is probably high-time individual investors do as well. These five stocks come with reliable dividends, are not overextended and are rated Buy at...
Monday's top analyst upgrades and downgrades included Alphabet, AppLovin, Facebook, Intel, Live Nation, Oracle, Pinterest, Smith & Wesson and SolarEdge.
With the stock market very overbought and interest rates still very close to generational lows, top-quality dividend stocks may be the way to go for the rest of 2021. Here are five that could offer...
These five outstanding stocks should continue to do well as the strong rotation to value continues. Toss in the added bonus of healthy dividends and there is a strong case for very proactive total...
These five Dividend Aristocrats have sizable upside to the Wall Street targets and pay at least 4%. In a market that is very long in the tooth, they make sense now.
Wednesday's top analyst upgrades and downgrades included Akamai Technologies, Carlyle, Ford, General Motors, JD.com, Moderna, Netflix, Peloton Interactive, Raytheon Technologies, Target, Tesla and...
Wednesday's top analyst upgrades, downgrades and initiations included Akamai Technologies, Alibaba, Boeing, Goodyear Tire & Rubber, Lyft, Micron Technology, Nvidia, T-Mobile, Under Armour, Wynn...